PMID- 17356131 OWN - NLM STAT- MEDLINE DCOM- 20070927 LR - 20210206 IS - 0006-4971 (Print) IS - 1528-0020 (Electronic) IS - 0006-4971 (Linking) VI - 110 IP - 1 DP - 2007 Jul 1 TI - Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. PG - 211-9 AB - Dendritic cells (DCs) determine whether antigen presentation leads to immune activation or to tolerance. Tolerance-inducing DCs (also called regulatory DCs) act partly by generating regulatory T lymphocytes (Tregs). The mechanism used by DCs to switch toward regulatory DCs during their differentiation is unclear. We show here that human DCs treated in vitro with glucocorticoids produce the glucocorticoid-induced leucine zipper (GILZ). Antigen presentation by GILZ-expressing DCs generates CD25(high)FOXP3(+)CTLA-4/CD152(+) and interleukin-10-producing Tregs inhibiting the response of CD4(+) and CD8(+) T lymphocytes. This inhibition is specific to the antigen presented, and only proliferating CD4(+) T lymphocytes express the Treg markers. Interleukin-10 is required for Treg induction by GILZ-expressing DCs. It is also needed for the suppressive function of Tregs. Antigen-presenting cells from patients treated with glucocorticoids generate interleukin-10-secreting Tregs ex vivo. These antigen-presenting cells produce GILZ, which is needed for Treg induction. Therefore, GILZ is critical for commitment of DCs to differentiate into regulatory DCs and to the generation of antigen-specific Tregs. This mechanism may contribute to the therapeutic effects of glucocorticoids. FAU - Hamdi, Haifa AU - Hamdi H AD - Institut National de la Sante et de la Recherche Medicale, Clamart, France. FAU - Godot, Veronique AU - Godot V FAU - Maillot, Marie-Christine AU - Maillot MC FAU - Prejean, Maria Victoria AU - Prejean MV FAU - Cohen, Nicolas AU - Cohen N FAU - Krzysiek, Roman AU - Krzysiek R FAU - Lemoine, Francois M AU - Lemoine FM FAU - Zou, Weiping AU - Zou W FAU - Emilie, Dominique AU - Emilie D LA - eng GR - R01 HL074399/HL/NHLBI NIH HHS/United States GR - R01 HL079584/HL/NHLBI NIH HHS/United States GR - R01 HL080499/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070313 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Glucocorticoids) RN - 0 (TSC22D3 protein, human) RN - 0 (Transcription Factors) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Antigen Presentation/*immunology MH - Cell Communication/immunology MH - Cell Differentiation/drug effects MH - Dendritic Cells/cytology/*immunology MH - Glucocorticoids/*pharmacology MH - Humans MH - Immunophenotyping MH - Interleukin-10/immunology MH - *T-Cell Antigen Receptor Specificity MH - T-Lymphocytes, Regulatory/*immunology MH - Transcription Factors/*biosynthesis/drug effects PMC - PMC2077304 COIS- Conflict-of-interest disclosure: The author declares no competing financial interests. ■ EDAT- 2007/03/16 09:00 MHDA- 2007/09/28 09:00 PMCR- 2008/11/15 CRDT- 2007/03/16 09:00 PHST- 2007/03/16 09:00 [pubmed] PHST- 2007/09/28 09:00 [medline] PHST- 2007/03/16 09:00 [entrez] PHST- 2008/11/15 00:00 [pmc-release] AID - S0006-4971(20)41327-8 [pii] AID - 2007/107896 [pii] AID - 10.1182/blood-2006-10-052506 [doi] PST - ppublish SO - Blood. 2007 Jul 1;110(1):211-9. doi: 10.1182/blood-2006-10-052506. Epub 2007 Mar 13.